Shiro Shibayama

1.5k citations
26 papers · 1.2k indexed · 1 hit paper · h-index 13
  • Virology top 2%
    • HIV Research and Treatment 9
  • Immunology top 5%
    • Immune Cell Function and Interaction 8
    • Mast cells and histamine 6
    • Immunotherapy and Immune Responses 6
    • T-cell and B-cell Immunology 4
  • Oncology top 10%
    • Chemokine receptors and signaling 4
    • HIV/AIDS drug development and treatment 6
    • Asthma and respiratory diseases 7

Shiro Shibayama

26 papers receiving 1.2k citations

Hit Papers

IFN-α Directly Promotes Programmed Cell Death-1 Transcrip...278201120262016202150100150200250

Peers

Shiro Shibayama
Comparison fields: 5 of 79
  • Virology 288
  • Immunology 662
  • Oncology 414
  • Infectious Diseases 206
  • Immunology and Allergy 50
Replace Timothy J. Colby with:
Timothy J. Colby United States
Sandra L. Gould United States
Eduardo Pauls Spain
M Guigon France
James Greger United States
Isabelle Girault France
Emil H. Palacios United States
Zhaowen Luo United States
Marianna Dioszegi United States
Ronald Rooke France
Shiro Shibayama relative to Timothy J. Colby United States Timothy J. Colby's profile →
Citations per field
00.5×4.7×
Timothy J. Colby · 1×
Citations per year

Countries citing papers authored by Shiro Shibayama

Since Specialization
Citations

This map shows the geographic impact of Shiro Shibayama's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shiro Shibayama with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shiro Shibayama more than expected).

Fields of papers citing papers by Shiro Shibayama

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shiro Shibayama. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shiro Shibayama. The network helps show where Shiro Shibayama may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Shiro Shibayama, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Shiro Shibayama Line = papers co-authored together Shiro Shibayama links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 202124
2 201911
3 20185
4 20171
5 20168
6 201316
7 20134
8 201286
9 20116
10
IFN-α Directly Promotes Programmed Cell Death-1 Transcription and Limits the Duration of T Cell-Mediated Immunitybreakdown →
2011278
11 201011
12 20107
13 201057
14 2009167
15 200914
16 200810
17 200637
18 200660
19 2004188
20 2001102

About Shiro Shibayama

Shiro Shibayama is a scholar working on Virology, Immunology and Allergy and Immunology, having authored 26 papers that have together received 1.2k indexed citations. Recurring topics across this work include HIV Research and Treatment (9 papers), Immune Cell Function and Interaction (8 papers), Asthma and respiratory diseases (7 papers), Mast cells and histamine (6 papers), Immunotherapy and Immune Responses (6 papers), HIV/AIDS drug development and treatment (6 papers), Chemokine receptors and signaling (4 papers) and T-cell and B-cell Immunology (4 papers). The work is most often cited by research in Virology (288 citations), Immunology (662 citations) and Oncology (414 citations). Shiro Shibayama has collaborated with scholars based in Japan, United States and United Kingdom. Frequent co-authors include Tasuku Honjo, Shunsuke Chikuma, Tamon Hayashi, Seigo Terawaki, Taku Okazaki, Takao Yoshida, Kenji Maeda, Hiroaki Mitsuya, Daikichi Fukushima and Kenji Sagawa. Their work appears in journals such as Journal of Biological Chemistry, Nature Immunology and The Journal of Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026